Effect of azithromycin on a red complex polymicrobial biofilm

References

• Petersilka GJ, Ehmke B, Flemmig TF. Antimicrobial effects of mechanical debridement. Periodontol 2000. 2002;28:1–7.
   Web of Science ®Google Scholar
• Gordon J, Walker C, Lamster I, et al. Efficacy of clindamycin hydrochloride in refractory periodontitis. 12-month results. J Periodontol. 1985;56:75–80.
   Google Scholar
• van Winkelhoff AJ, Tijhof CJ, de Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol. 1992;63:52–57.
   PubMed Web of Science ®Google Scholar
• Slots J. Low-cost periodontal therapy. Periodontol 2000. 2012;60:110–137.
   Web of Science ®Google Scholar
• Addy M, Wright R. Comparison of the in vivo and in vitro antibacterial properties of providone iodine and chlorhexidine gluconate mouthrinses. J Clin Periodontol. 1978;5:198–205.
   PubMed Web of Science ®Google Scholar
• Fine DH, Furgang D, Barnett ML. Comparative antimicrobial activities of antiseptic mouthrinses against isogenic planktonic and biofilm forms of Actinobacillus actinomycetemcomitans. J Clin Periodontol. 2001;28:697–700.
   PubMed Web of Science ®Google Scholar
• Kara D, Luppens SB, Cate JM. Differences between single- and dual-species biofilms of Streptococcus mutans and Veillonella parvula in growth, acidogenicity and susceptibility to chlorhexidine. Eur J Oral Sci. 2006;114:58–63.
   PubMed Web of Science ®Google Scholar
• Noiri Y, Okami Y, Narimatsu M, et al. Effects of chlorhexidine, minocycline, and metronidazole on Porphyromonas gingivalis strain 381 in biofilms. J Periodontol. 2003;74:1647–1651.
   Web of Science ®Google Scholar
• Appelbaum PC, Chatterton SA. Susceptibility of anaerobic bacteria to ten antimicrobial agents. Antimicrob Agents Chemother. 1978;14:371–376.
   PubMed Web of Science ®Google Scholar
• Baker PJ, Slots J, Genco RJ, et al. Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria. Antimicrob Agents Chemother. 1983;24:420–424.
   Web of Science ®Google Scholar
• Newman MG, Hulem C, Colgate J, et al. Antibacterial susceptibility of plaque bacteria. J Dent Res. 1979;58:1722–1732.
   Web of Science ®Google Scholar
• Poulet PP, Duffaut D, Lodter JP. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease. J Clin Periodontol. 1999;26:261–263.
   PubMed Web of Science ®Google Scholar
• Sbordone L, Barone A, Ramaglia L, et al. Antimicrobial susceptibility of periodontopathic bacteria associated with failing implants. J Periodontol. 1995;66:69–74.
   Web of Science ®Google Scholar
• Slots J, Evans RT, Lobbins PM, et al. In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother. 1980;18:9–12.
   PubMed Web of Science ®Google Scholar
• Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25:134–144.
   PubMed Web of Science ®Google Scholar
• Byrne SJ, Dashper SG, Darby IB, et al. Progression of chronic periodontitis can be predicted by the levels of Porphyromonas gingivalis and Treponema denticola in subgingival plaque. Oral Microbiol Immunol. 2009;24:469–477.
   PubMedGoogle Scholar
• Kesavalu L, Sathishkumar S, Bakthavatchalu V, et al. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun. 2007;75:1704–1712.
   PubMed Web of Science ®Google Scholar
• Belibasakis GN, Thurnheer T. Validation of antibiotic efficacy on in vitro subgingival biofilms. J Periodontol. 2014;85:343–348.
   PubMed Web of Science ®Google Scholar
• Feres M, Figueiredo LC, Soares GM, et al. Systemic antibiotics in the treatment of periodontitis. Periodontol 2000. 2015;67:131–186.
   PubMed Web of Science ®Google Scholar
• Mombelli A, Cionca N, Almaghlouth A, et al. Are there specific benefits of amoxicillin plus metronidazole in Aggregatibacter actinomycetemcomitans-associated periodontitis? Double-masked, randomized clinical trial of efficacy and safety. J Periodontol. 2013;84:715–724.
   PubMed Web of Science ®Google Scholar
• Amsden GW. Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther. 1996;18:56–72; discussion 55.
   PubMed Web of Science ®Google Scholar
• Gomi K, Yashima A, Nagano T, et al. Effects of full-mouth scaling and root planing in conjunction with systemically administered azithromycin. J Periodontol. 2007;78:422–429.
   PubMed Web of Science ®Google Scholar
• Haas AN, de Castro GD, Moreno T, et al. Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial. J Clin Periodontol. 2008;35:696–704.
   Web of Science ®Google Scholar
• Hirsch R, Deng H, Laohachai MN. Azithromycin in periodontal treatment: more than an antibiotic. J Periodontal Res. 2012;47:137–148.
   PubMed Web of Science ®Google Scholar
• Sefton AM, Maskell JP, Beighton D, et al. Azithromycin in the treatment of periodontal disease. Effect on Microbial Flora. J Clin Periodontol. 1996;23:998–1003.
   PubMed Web of Science ®Google Scholar
• Yashima A, Gomi K, Maeda N, et al. One-stage full-mouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin. J Periodontol. 2009;80:1406–1413.
   Web of Science ®Google Scholar
• Retsema J, Girard A, Schelkly W, et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother. 1987;31:1939–1947.
   PubMed Web of Science ®Google Scholar
• Bartold PM, du Bois AH, Gannon S, et al. Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis. Inflammopharmacology. 2013;21:321–338.
   PubMed Web of Science ®Google Scholar
• Leschine SB, Canale-Parola E. Rifampin as a selective agent for isolation of oral spirochetes. J Clin Microbiol. 1980;12:792–795.
   Web of Science ®Google Scholar
• Kesavalu L, Walker SG, Holt SC, et al. Virulence characteristics of oral treponemes in a murine model. Infect Immun. 1997;65:5096–5102.
   PubMed Web of Science ®Google Scholar
• Orth R, O’Brien-Simpson N, Dashper S, et al. An efficient method for enumerating oral spirochetes using flow cytometry. J Microbiol Methods. 2010;80:123–128.
   Web of Science ®Google Scholar
• Dashper S, O’Brien-Simpson N, Liu SW, et al. Oxantel disrupts polymicrobial biofilm development of periodontal pathogens. Antimicrob Agents Chemother. 2014;58:378–385.
   Web of Science ®Google Scholar
• Dashper SG, Pan Y, Veith PD, et al. Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity. Antimicrob Agents Chemother. 2012;56:1548–1556.
   Web of Science ®Google Scholar
• Colombo AP, Boches SK, Cotton SL, et al. Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. J Periodontol. 2009;80:1421–1432.
   PubMed Web of Science ®Google Scholar
• Ximenez-Fyvie LA, Haffajee AD, Socransky SS. Microbial composition of supra- and subgingival plaque in subjects with adult periodontitis. J Clin Periodontol. 2000;27:722–732.
   PubMed Web of Science ®Google Scholar
• Zijnge V, van Leeuwen MB, Degener JE, et al. Oral biofilm architecture on natural teeth. PLoS One. 2010;5:e9321.
   PubMed Web of Science ®Google Scholar
• Vesey PM, Kuramitsu HK. Genetic analysis of Treponema denticola ATCC 35405 biofilm formation. Microbiology. 2004;150:2401–2407.
   Web of Science ®Google Scholar
• Davey ME, Duncan MJ. Enhanced biofilm formation and loss of capsule synthesis: deletion of a putative glycosyltransferase in Porphyromonas gingivalis. J Bacteriol. 2006;188:5510–5523.
   PubMed Web of Science ®Google Scholar
• Yamada M, Ikegami A, Kuramitsu HK. Synergistic biofilm formation by Treponema denticola and Porphyromonas gingivalis. FEMS Microbiol Lett. 2005;250:271–277.
   PubMed Web of Science ®Google Scholar
• Onagawa M, Ishihara K, Okuda K. Coaggregation between Porphyromonas gingivalis and Treponema denticola. Bull Tokyo Dent Coll. 1994;35:171–181.
   Google Scholar
• Grenier D. Nutritional interactions between two suspected periodontopathogens, Treponema denticola and Porphyromonas gingivalis. Infect Immun. 1992;60:5298–5301.
   PubMed Web of Science ®Google Scholar
• Ikegami A, Honma K, Sharma A, et al. Multiple functions of the leucine-rich repeat protein LrrA of Treponema denticola. Infect Immun. 2004;72:4619–4627.
   Web of Science ®Google Scholar
• Sharma A, Inagaki S, Sigurdson W, et al. Synergy between Tannerella forsythia and Fusobacterium nucleatum in biofilm formation. Oral Microbiol Immunol. 2005;20:39–42.
   PubMedGoogle Scholar
• Yoneda M, Yoshikane T, Motooka N, et al. Stimulation of growth of Porphyromonas gingivalis by cell extracts from Tannerella forsythia. J Periodontal Res. 2005;40:105–109.
   Web of Science ®Google Scholar
• Kuramitsu HK, Chen W, Ikegami A. Biofilm formation by the periodontopathic bacteria Treponema denticola and Porphyromonas gingivalis. J Periodontol. 2005;76:2047–2051.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Dashper SG, Chen YY, et al. Porphyromonas gingivalis and Treponema denticola synergistic polymicrobial biofilm development. PLoS One. 2013;8:e71727.
   PubMed Web of Science ®Google Scholar
• Soares GM, Teles F, Starr JR, et al. Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model. Antimicrob Agents Chemother. 2015;59:2791–2798.
   Web of Science ®Google Scholar
• Tenenbaum H, Jehl F, Gallion C, et al. Amoxicillin and clavulanic acid concentrations in gingival crevicular fluid. J Clin Periodontol. 1997;24:804–807.
   Web of Science ®Google Scholar
• Pahkla ER, Koppel T, Saag M, et al. Metronidazole concentrations in plasma, saliva and periodontal pockets in patients with periodontitis. J Clin Periodontol. 2005;32:163–166.
   PubMed Web of Science ®Google Scholar
• Muniz FW, de Oliveira CC, de Sousa Carvalho R, et al. Azithromycin: a new concept in adjuvant treatment of periodontitis. Eur J Pharmacol. 2013;705:135–139.
   PubMed Web of Science ®Google Scholar
• Sampaio E, Rocha M, Figueiredo LC, et al. Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol. 2011;38:838–846.
   PubMed Web of Science ®Google Scholar
• Schreiber F, Szewzyk U. Environmentally relevant concentrations of pharmaceuticals influence the initial adhesion of bacteria. Aquat Toxicol. 2008;87:227–233.
   PubMed Web of Science ®Google Scholar
• Maezono H, Noiri Y, Asahi Y, et al. Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis. Antimicrob Agents Chemother. 2011;55:5887–5892.
   Web of Science ®Google Scholar
• Tamura A, Ara T, Imamura Y, et al. The effects of antibiotics on in vitro biofilm model of periodontal disease. Eur J Med Res. 2008;13:439–445.
   PubMed Web of Science ®Google Scholar
• Jain N, Lai PC, Walters JD. Effect of gingivitis on azithromycin concentrations in gingival crevicular fluid. J Periodontol. 2012;83:1122–1128.
   Web of Science ®Google Scholar
• Lai PC, Ho W, Jain N, et al. Azithromycin concentrations in blood and gingival crevicular fluid after systemic administration. J Periodontol. 2011;82:1582–1586.
   Web of Science ®Google Scholar
• Haffajee AD, Patel M, Socransky SS. Microbiological changes associated with four different periodontal therapies for the treatment of chronic periodontitis. Oral Microbiol Immunol. 2008;23:148–157.
   PubMedGoogle Scholar
• van Winkelhoff AJ, Herrera D, Oteo A, et al. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol. 2005;32:893–898.
   PubMed Web of Science ®Google Scholar
• Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol. 2007;34:243–253.
   PubMed Web of Science ®Google Scholar
• Lindhe J, Liljenberg B, Adielson B, et al. Use of metronidazole as a probe in the study of human periodontal disease. J Clin Periodontol. 1983;10:100–112.
   PubMed Web of Science ®Google Scholar
• Listgarten MA, Lindhe J, Hellden L. Effect of tetracycline and/or scaling on human periodontal disease. Clinical, microbiological, and histological observations. J Clin Periodontol. 1978;5:246–2471.
   PubMed Web of Science ®Google Scholar
• Dastoor SF, Travan S, Neiva RF, et al. Effect of adjunctive systemic azithromycin with periodontal surgery in the treatment of chronic periodontitis in smokers: a pilot study. J Periodontol. 2007;78:1887–1896.
   Web of Science ®Google Scholar
• Mombelli A, Gusberti FA, Lang NP. Treatment of recurrent periodontal disease by root planing and Ornidazole (Tiberal). Clinical and microbiological findings. J Clin Periodontol. 1989;16:38–45.
   Web of Science ®Google Scholar
• Soares GM, Figueiredo LC, Faveri M, et al. Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs. J Appl Oral Sci. 2012;20:295–309.
   PubMed Web of Science ®Google Scholar
• Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135–138.
   PubMed Web of Science ®Google Scholar
• Teles R, Teles F, Frias-Lopez J, et al. Lessons learned and unlearned in periodontal microbiology. Periodontol 2000. 2013;62:95–162.
   PubMed Web of Science ®Google Scholar
• Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol. 2002;17:267–271.
   PubMedGoogle Scholar
• Wright TL, Ellen RP, Lacroix JM, et al. Effects of metronidazole on Porphyromonas gingivalis biofilms. J Periodontal Res. 1997;32:473–477.
   Web of Science ®Google Scholar